| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Guy Hardwick maintains Amphenol (NYSE:APH) with a Equal-Weight and raises the price target from $120 to $143.
Jim Cramer finds Aquestive Therapeutics very interesting, while Amphenol Corporation is a great stock. Joby Aviation is losing ...
Big Tech's capital spending is up significantly, with Meta, Microsoft and Google leading the charge in AI infra. Hidden win...
UBS analyst Joseph Spak maintains Amphenol (NYSE:APH) with a Buy and raises the price target from $145 to $152.